10x Genomics, Inc. ( TXG) - Stock Earnings
TXG Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
TXG Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -27.5 million USD | 149.0 million USD |
| 2025Q4 | -16.3 million USD | 166.0 million USD |
| 2026Q1 | -13.5 million USD | 150.8 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
TXG Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -255.1 million USD | 618.7 million USD |
| 2024 | -182.6 million USD | 610.8 million USD |
| 2025 | -43.5 million USD | 642.8 million USD |
| 2026 Est. | — | — |
TXG
Price: $47.20
Earnings Per Share: -0.17 USD
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Country: United States
Volume: 10738
Market Capitalization: 5.0 billion